Immediate Impact

61 standout
Sub-graph 1 of 24

Citing Papers

Pan-PPAR agonist lanifibranor improves insulin resistance and hepatic steatosis in patients with T2D and MASLD
2025 Standout
Strategies to reduce the risks of mRNA drug and vaccine toxicity
2024 Standout
2 intermediate papers

Works of J. E. Dinger being referenced

A microfluidically perfused three dimensional human liver model
2015

Author Peers

Author Last Decade Papers Cites
J. E. Dinger 82 57 115 177 85 12 420
Paul A. Bombardt 35 24 199 34 18 13 401
Tracy Walker 50 30 169 76 56 11 386
Michiel W. den Braver 125 52 152 204 123 11 490
B. Kevin Park 151 30 146 24 45 15 472
Márcia Monteiro 20 24 353 106 5 12 509
Sylvie Klieber 186 48 117 127 111 18 418
Muriel Saulnier 53 15 140 28 11 13 422
Sylvie Dupin 213 12 132 21 13 9 428
Alenka Chapron 79 35 153 209 11 10 455
Karen Fried 69 21 115 93 4 15 509

All Works

Loading papers...

Rankless by CCL
2026